Typicality: | 0.341 |
Saliency: | 0.419 |
in early clinical trials | 11 | location |
in the early 2000s | 7 | temporal |
in smaller u.s. studies | 7 | location |
vaccine → show → promise | 37 |
vaccine → shown → promise | 17 |
vaccine → be shown → promise | 5 |
vaccine → shown → great promise | 3 |
vaccine → show → great promise | 3 |
negative | neutral | positive |
0.104 | 0.266 | 0.629 |
Raw frequency | 65 |
Normalized frequency | 0.419 |
Modifier score | 0.500 |
Perplexity | 355.693 |